(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | --22.04M | 6.51%259.09M | 20.58%243.26M | 25.51%106.26M | -2.57%201.74M | --84.67M | 20.13%207.07M | 38.41%172.38M | --124.55M |
Operating income | 22.04M | 6.51%259.09M | 20.58%243.26M | 25.51%106.26M | -2.57%201.74M | 84.67M | 20.13%207.07M | 38.41%172.38M | 124.55M |
Cost of sales | ---14.21M | -25.26%-173.65M | -34.77%-138.62M | -39.45%-63.72M | 21.90%-102.86M | ---45.7M | -32.85%-131.7M | -21.23%-99.14M | ---81.77M |
Operating expenses | -14.21M | -25.26%-173.65M | -34.77%-138.62M | -39.45%-63.72M | 21.90%-102.86M | -45.7M | -32.85%-131.7M | -21.23%-99.14M | -81.77M |
Gross profit | 7.83M | -18.34%85.44M | 5.82%104.63M | 9.16%42.54M | 31.19%98.88M | 38.97M | 2.91%75.37M | 71.23%73.24M | 42.77M |
Selling expenses | ---2.43M | -4.10%-7.11M | 13.87%-6.83M | 16.85%-5.03M | -71.12%-7.93M | ---6.05M | -64.12%-4.63M | -55.28%-2.82M | ---1.82M |
Administrative expenses | ---13.18M | -70.77%-41.71M | 5.33%-24.43M | 3.04%-23.19M | -30.43%-25.8M | ---23.92M | -28.51%-19.78M | -58.23%-15.39M | ---9.73M |
Research and development expenses | ---1.5M | -4.82%-6.03M | 16.25%-5.75M | -48.41%-4.67M | -2.92%-6.86M | ---3.15M | 3.56%-6.67M | -23.02%-6.91M | ---5.62M |
Impairment and provision | ---- | 119.67%1.26M | ---6.39M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | 119.67%1.26M | ---6.39M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | ---2.68M | 44.91%5.73M | -18.27%3.96M | -12.84%3.22M | -5.67%4.84M | --3.7M | 367.21%5.13M | 29.79%1.1M | --846K |
Operating profit | -11.97M | -42.35%37.58M | 3.27%65.19M | 34.73%12.87M | 27.73%63.13M | 9.55M | 0.43%49.42M | 86.02%49.21M | 26.45M |
Financing cost | ---5.62M | -17.71%-10.48M | -8.89%-8.91M | -4.71%-6.4M | -48.35%-8.18M | ---6.11M | -276.90%-5.51M | -95.85%-1.46M | ---747K |
Share of profits of associates | ---- | 427.27%288K | 32.82%-88K | ---- | -114.10%-131K | ---130K | --929K | ---- | ---- |
Share of profit from joint venture company | ---413K | ---- | ---- | 25.97%-57K | ---33K | ---77K | ---- | ---- | ---- |
Earning before tax | -17.99M | -51.27%27.39M | 2.58%56.2M | 98.39%6.41M | 22.19%54.78M | 3.23M | -6.10%44.83M | 85.74%47.75M | 25.71M |
Tax | --2.96M | 33.64%-4.74M | 15.97%-7.14M | 110.82%120K | -57.49%-8.5M | ---1.11M | -6.18%-5.4M | -70.02%-5.08M | ---2.99M |
After-tax profit from continuing operations | -15.03M | -53.83%22.65M | 5.99%49.06M | 207.68%6.53M | 17.36%46.28M | 2.12M | -7.56%39.44M | 87.81%42.66M | 22.72M |
Earning after tax | -15.03M | -53.83%22.65M | 5.99%49.06M | 207.68%6.53M | 17.36%46.28M | 2.12M | -7.56%39.44M | 87.81%42.66M | 22.72M |
Minority profit | ---140K | -182.98%-234K | -7.54%282K | -63.77%146K | --305K | --403K | ---- | ---- | ---- |
Profit attributable to shareholders | -14.89M | -53.09%22.88M | 6.08%48.77M | 271.28%6.39M | 16.58%45.98M | 1.72M | -7.56%39.44M | 87.81%42.66M | 22.72M |
Basic earnings per share | -0.03 | -53.85%0.06 | -100.00%0.13 | 1K | 16.75%4.6K | -99.99%3.94K | 42.66M | ||
Diluted earnings per share | -0.03 | -53.85%0.06 | -100.00%0.13 | 1K | 16.75%4.6K | -99.99%3.94K | 42.66M | ||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | KPMG | -- | KPMG | -- | KPMG | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data